News Daily News Fish Oils: Yes for HF and Secondary Prevention, No for the General Population, Says AHA Michael O'Riordan March 15, 2017
News Daily News NOACs Seem to Perform Just Fine in Patients With A-fib and Most Types of Valvular Disease Todd Neale March 14, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular News and Features for 2016 Shelley Wood December 29, 2016
News Daily News More A-fib, No Drop in Stroke or Death With Surgical Left Atrial Appendage Exclusion Todd Neale December 05, 2016
Presentation AHA 2016 PIONEER Trial: An OPen-label, Randomized, Controlled, Multicenter Study ExplorIng TwO TreatmeNt StratEgiEs of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy Presenter: Michael Gibson November 15, 2016
News Daily News Conduction Problems Requiring Permanent Pacemakers Continue to Vex TAVR Field Todd Neale November 08, 2016
News Opinion Editor's Corner TCT 2016 My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway Shelley Wood November 07, 2016
News Conference News ESC 2016 New ESC A-fib Guidelines Call for Integrated Care for All Patients Todd Neale August 27, 2016
News Daily News New-Onset A-Fib, Chronic Kidney Disease Are Risk Factors For Stroke After TAVR, Meta-Analysis Shows Yael L. Maxwell August 10, 2016
News Daily News Publica la AHA declaración sobre los desfibriladores portátiles y advierte que los datos sobre su eficacia son limitados Michael O'Riordan March 31, 2016
News Daily News AHA Issues Statement on Wearable Defibrillators, Cautions That Effectiveness Data Are Limited Michael O'Riordan March 31, 2016